Print
Email
Share

Nasal swine flu vaccine recalled over potency

Nasal swine flu vaccine recalled over potency

Credit: KING

Nasal swine flu vaccine recalled over potency

by Associated Press

NWCN.com

Posted on December 22, 2009 at 3:24 PM

WASHINGTON, D.C. -  Drugmaker Medimmune is recalling nearly 5 million doses of swine flu vaccine because the nasal spray appears to lose strength over time.

The Food and Drug Administration said Tuesday that the vaccine is safe and patients who received the product should be protected from the H1N1 virus.

The FDA says the vast majority of the doses have already been distributed and used. Agency officials say the vaccine met potency specifications when it was distributed in October and November.

Last week, another vaccine maker recalled swine flu shots for children because tests indicated those doses lost some strength.

Print
Email
Share

Forgot Password?

Don't have an account?

Register Now

Member Benefits

Link your account to your Twitter or Facebook account for easier login!

Link your account to your Facebook profile Link your account to your Twitter profile

Check box to receive Free Special Offers

* - Indicates required field

Check box to receive Free Special Offers

Connecting to

You may need to allow pop up window for this step of registration

Just one more step:

Please take a moment to review the available e-mail newsletters has to offer. Place a checkbox next to the newsletters you wish to subscribe to.

Welcome.

Thank you for becoming a member of NWCN.com. You now have full access to the best local coverage and late breaking news from NWCN.com. Soon you will be redirected to the page you were seeking, and a confirmation email will be delivered to you.

You will need to respond to the confirmation e-mail for your account to be activated.

NWCN.com is dedicated to bringing you exceptional news and outstanding information services, all while personalizing it to your liking. We're sure you'll enjoy being a NWCN.com member! If you need assistance, please contact us.